During the past decade, Ningbo Medical Center Lihuili Hospital conducted 15 clinical trials. In the 10-year time frame, 15 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 15 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Ningbo Medical Center Lihuili Hospital" #1 sponsor was "First Affiliated Hospital of Zhejiang University" with 2 trials, followed by "Second Affiliated Hospital, School of Medicine, Zhejiang University" with 2 trials sponsored, "Zhejiang Cancer Hospital" with 2 trials sponsored, "Abbott Medical Devices" with 1 trials sponsored and "Chia Tai Tianqing Pharmaceutical Group Co., Ltd." with 1 trials sponsored. Other sponsors include 2 different institutions and companies that sponsored additional 12 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Ningbo Medical Center Lihuili Hospital" #1 collaborator was "Fujian Medical University Union Hospital" with 1 trials as a collaborator, "Jiangsu Hansoh Pharmaceutical Co., Ltd." with 1 trials as a collaborator, "Jiangsu HengRui Medicine Co., Ltd." with 1 trials as a collaborator, "Ningbo Medical Center Lihuili Hospital" with 1 trials as a collaborator and "Shanghai Chest Hospital" with 1 trials as a collaborator. Other collaborators include -1 different institutions and companies that were collaborators in the rest 9 trials.

According to Clinical.Site data, the most researched conditions in "Ningbo Medical Center Lihuili Hospital" are "Aortic Valve Disease" (1 trials), "Colonic Polyp" (1 trials), "Crohn Disease" (1 trials), "Esophageal Neoplasms" (1 trials) and "Esophageal Squamous Cell Carcinoma" (1 trials). Many other conditions were trialed in "Ningbo Medical Center Lihuili Hospital" in a lesser frequency.

Most popular intervention types in "Ningbo Medical Center Lihuili Hospital" are "Drug" (8 trials), "Device" (3 trials), "Procedure" (2 trials), "Dietary Supplement" (1 trials) and "Radiation" (1 trials). Other intervention types were less common.

The name of intervention was led by "Abbott Mechanical Heart Valve (MHV) Regent™" (1 trials), "Anlotinib" (1 trials), "Anlotinib(blank)" (1 trials), "CEMR" (1 trials) and "EMR-P" (1 trials). Other intervention names were less common.

The vast majority of trials in "Ningbo Medical Center Lihuili Hospital" are 15 trials for "All" genders.

Currently, there are NaN active trials in "Ningbo Medical Center Lihuili Hospital". 2 are not yet recruiting, 10 are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were undefined completed trials in Ningbo Medical Center Lihuili Hospital, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Ningbo Medical Center Lihuili Hospital, 0 "Phase 1" clinical trials were conducted, 4 "Phase 2" clinical trials and 4 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 3 trials that are defined as “Not Applicable".